13F
← All fund report cards

Capital Research Global Investors

13F equity value
$644.6B
Positions
459
Top 10 concentration
35.3%
Quarters / total new picks
32 / 603
13F equity value over time
$0M$322B$645B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.7% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 62.5% of quarters (excess t = 0.82, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.2%
t-stat
0.82
Quarterly win rate
63%
Annualized excess
+3.5%
$1 → follow vs universe
$2.69 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.14720180630: follow 1.13620180930: follow 1.20520181231: follow 1.26120190331: follow 1.26720190630: follow 1.42420190930: follow 1.57520191231: follow 1.29420200331: follow 1.64020200630: follow 1.86320200930: follow 2.24620201231: follow 2.33020210331: follow 2.44920210630: follow 2.58620210930: follow 1.99920211231: follow 1.71220220331: follow 1.75220220630: follow 1.64120220930: follow 1.87520221231: follow 1.84720230331: follow 1.80220230630: follow 1.85020230930: follow 2.23220231231: follow 2.31520240331: follow 2.32120240630: follow 2.63320240930: follow 2.48220241231: follow 2.38720250331: follow 2.46320250630: follow 2.50520250930: follow 2.85320251231: follow 2.690 0.84 1.96 3.08 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 459 · 2026 Q1

Ticker Value Weight QoQ
AVGO $35.9B
5.6%
ADD
MSFT $35.6B
5.5%
ADD
NVDA $33.7B
5.2%
ADD
AMZN $24.7B
3.8%
ADD
LLY $22.7B
3.5%
HOLD
META $17.7B
2.7%
ADD
GOOGL $16.5B
2.6%
ADD
AAPL $16.3B
2.5%
ADD
PM $13.2B
2.1%
ADD
GOOG $11.6B
1.8%
ADD
RTX $10.1B
1.6%
TRIM
AMAT $10.1B
1.6%
TRIM
GE $9.9B
1.5%
ADD
VRTX $9.4B
1.5%
ADD
SBUX $9.2B
1.4%
ADD
UBER $8.4B
1.3%
ADD
JPM $8.1B
1.3%
ADD
CNQ $8.0B
1.2%
ADD
LIN $8.0B
1.2%
ADD
RCL $7.8B
1.2%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.